Trial intelligence / Profile preview

Sucralfate for prevention of acute radiation proctitis in cancer patients

IRCT201606042027N7Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sucralfate in Acute radiation proctitis (ARP), sponsored by Mazandaran University of Medical Sciences. Started Nov 2015; status: completed.

02

Drugs

sucralfate
03

Conditions

Acute radiation proctitis (ARP)

Beyond the preview

Go deeper on IRCT201606042027N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201606042027N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call